Circulating Dipeptidyl Peptidase 3 is a Myocardial Depressant Factor: Dipeptidyl Peptidase 3 Inhibition Rapidly and Sustainably Improves Haemodynamics
Benjamin Deniau(Inserm), Alice Blet(Inserm), Heli Tolpannen(University of Helsinki), Fériel Azibani(Inserm), Paul Robert Koundé(Inserm), Karine Santos(Radboud University Nijmegen), Andreas Bergmann(Agostino Gemelli University Polyclinic), Anke Dienelt(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Jane‐Lise Samuel(Université Paris Cité), Malha Sadoune(Inserm), Johan Lassus(University of Helsinki), Linda Rehfeld(Henkel (Germany)), Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), Nicolas Vodovar(Institut Pasteur), Veli‐Pekka Harjola(Polskie Towarzystwo Gastroenterologii), Oliver Hartmann
Cited by 106
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Journal of Heart Failure|2022|2.1k